Cronos plots doctor growth as firm eyes A$100m of revenue in FY23 by Steve Jones September 8, 2022April 29, 2024 Increasing numbers of doctors are showing a willingness to embrace medicinal cannabis, Cronos Australia has said, […]
As we build Australia’s medicinal cannabis industry, it’s important to remember history is on our side by Rodney Cocks September 7, 2022April 29, 2024
Cronos to pay shareholder dividend after reporting A$6m profit by Steve Jones August 29, 2022April 29, 2024
Cronos beds down merger with CDA as upgraded CanView platform prepares to launch by Steve Jones April 28, 2022April 29, 2024
ACannabis is back, with an exclusive offer for Cannabiz members by cannabiz team February 8, 2022April 29, 2024
Company news: Cronos; ECS Botanics; Elixinol; Zelira; Medlab; Emyria; Creso; MGC Pharma; Botanix; Incannex by Martin Lane February 2, 2022April 29, 2024
Cronos Australia and CDA Health complete ‘game-changing’ deal by Steve Jones December 16, 2021April 29, 2024
Company news: Cann Group; Releaf Group; Elixinol Wellness; Cronos Australia; Auscann; Zelira; Emyria; Incannex by cannabiz team October 21, 2021April 29, 2024